Updates

CSRxP: BIDEN ADMINISTRATION TAKES IMPORTANT STEP TO PROTECT SENIORS & TAXPAYERS WITH DELAY OF REBATE RULE

Jan 29, 2021

HHS Pause of Misguided, Pharma-Backed Policy Will Help Refocus Attention on Read More

ICYMI: STUDY FINDS U.S. BRAND NAME DRUG PRICES “SIGNIFICANTLY HIGHER” THAN THOSE IN OTHER COUNTRIES

Jan 28, 2021

New RAND Report Finds Rx Prices in U.S. Average 3.44 Times Higher Than Those Read More

PRESCRIPTION FOR CHANGE: WHY DRUG PRICES ARE OUT-OF-CONTROL AND HOW TO FIX IT

Jan 28, 2021

CSRxP Briefing Covers Impact of Affordability Crisis, Drug Company’s Read More

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON & NOVARTIS

Jan 27, 2021

Price Hikes Fuel Sky-High Earnings For Brand Name Giants As millions of Read More

CSRXP POLL: AMERICANS EXPECT NEW ADMINISTRATION & CONGRESS TO ACT ON OUT-OF-CONTROL DRUG PRICES, HOLD BIG PHARMA ACCOUNTABLE

Jan 26, 2021

Clear Majority of Voters Identify Rx Drug Affordability as Top Issue and Read More

CSRXP WELCOMES GOVERNOR CUOMO INVESTIGATION OF DRUG COMPANIES’ PANDEMIC PRICE-GOUGING

Jan 22, 2021

Investigation Will Shed Light On Big Pharma’s Price Hikes During Public Read More

CSRXP: SENATE FINANCE REPORT HIGHLIGHTS BIG PHARMA’S EGREGIOUS PRACTICES THAT RAISE INSULIN PRICES

Jan 14, 2021

Bipartisan Investigation Details How Drug Companies Work in Tandem to Hike Read More

BIG PHARMA WATCH: NEW STUDY FINDS DRUG COMPANIES CONTINUING TO HIKE PRICES WITHOUT IMPROVING THEIR DRUGS

Jan 13, 2021

Unjustified Rx Price Increases Cost American Patients & Health System Read More

CSRxP STATEMENT ON PCMA LAWSUIT CHALLENGING TRUMP ADMINISTRATION’S REBATE RULE

Jan 12, 2021

Misguided Policy Published in Violation of Legally Required Process for Public Read More

BIG PHARMA WATCH: HEADLINES FROM BIG PHARMA’S NEW YEAR PRICE HIKES

Jan 11, 2021

Second Major Round of Pandemic Price Increases Underscores Urgency for Read More

HAPPY NEW YEAR: BIG PHARMA HIKES PRICES ON MORE THAN 580 RX DRUGS TO START 2021

Jan 4, 2021

Drug Companies Double Down In Second Major Round Of Pandemic Price Hikes As Read More

“DOSE OF REALITY” BIG PHARMA’S YEAR OF BAD BEHAVIOR

Dec 31, 2020

Part IV: Escalating Assault on 340B Program for Providers Serving America’s Read More